WeGovy - amhwellness.co.uk

Wegovy

Average weight loss: Up to 18.7%*

Starting at

National Health Service

Wegovy is available on the NHS to support weight management. It can be taken on its own or with other diabetes medications.

Novo Nordisk

The drug manufacturer Novo Nordisk sponsored a trial of Wegovy that found it reduced major cardiovascular events by 20%.

National Institute for Health and Care Excellence

The NICE approved Wegovy for managing obesity in the UK on September 4, 2023.

Average of 18.7% weight loss

*After 72 weeks of weekly Wegovy treatment, participants achieved 18.7% average weight loss (Source)

How Semaglutide Works

Mimics Natural Hormones

Semaglutide mimics the natural hormone GLP-1, which helps increase insulin production when blood sugar levels rise and reduces the amount of sugar the liver produces.

Slows Gastric Emptying

It slows the movement of food through the stomach, which helps control blood sugar after meals and helps you feel fuller for longer periods.

Reduces Appetite

By acting on the brain’s hunger centers, semaglutide helps curb appetite, making it easier to consume fewer calories and manage weight while supporting better blood sugar control.

Average of 18.7%* weight loss

*After 72 weeks of weekly Wegovy treatment, participants achieved 18.7% average weight loss (Source)

There's a reason why everyone is talking about AMH Wellness
It Works.

There's a reason why everyone is talking about AMH Wellness
It Works.

Select your Current Weight:

209 lbs

With us you could Lose:

38 lbs

Ready To Get Started On Your Weight Loss Journey?

Frequently asked question

Accordion Tab Title 1

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Accordion Tab Title 2

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Accordion Tab Title 3

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Accordion Tab Title 4

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Accordion Tab Title 5

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Accordion Tab Title 6

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Important Safety Information for Wegovy (Semaglutide) in the UK

Wegovy is a prescription medication used for weight management in adults with obesity or weight-related health conditions. While it can be effective, it’s essential to be aware of potential side effects and warnings associated with its use.

Common Side Effects:

Nausea
Diarrhoea
Vomiting
Constipation
Stomach pain
Headache
Fatigue

These side effects are commonly reported and may subside as your body adjusts to the medication. If they persist or become bothersome, consult your healthcare provider.

Serious Side Effects:

Although rare, some serious side effects may occur:

Pancreatitis: Severe and persistent stomach pain that may radiate to your back.
Gallbladder Issues: Symptoms include pain in the upper stomach, fever, yellowing of the skin or eyes (jaundice).
Kidney Problems: Dehydration from nausea, vomiting, or diarrhoea can lead to kidney issues.
Allergic Reactions: Signs include swelling of the face, lips, tongue, or throat, and difficulty breathing.

If you experience any of these symptoms, seek medical attention immediately.

Warnings:

Thyroid Tumors: In animal studies, semaglutide has been associated with thyroid C-cell tumors. It’s unclear if this applies to humans. Do not use Wegovy if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Hypoglycemia: Wegovy can lower blood sugar levels, especially in individuals with type 2 diabetes who are on insulin or other diabetes medications. Monitor your blood sugar levels regularly.

Drug Interactions:

Inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal supplements. Wegovy may affect the absorption of oral medications due to delayed gastric emptying. Close monitoring is advised when taken with medications that have a narrow therapeutic window, such as warfarin.

Usage Instructions:

Administration: Inject Wegovy once weekly, on the same day each week, at any time of day, with or without meals. It should be injected subcutaneously in the abdomen, thigh, or upper arm.
Dosage: Follow the dosing schedule as prescribed by your healthcare provider. Do not exceed the recommended dose.

Additional Considerations:

Hydration: Maintain adequate hydration, especially if experiencing gastrointestinal side effects.
Pregnancy and Breastfeeding: Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding, as Wegovy may not be recommended.
Storage: Store Wegovy pens in the refrigerator. If needed, they can be kept at room temperature (up to 30°C) for up to 28 days.

Reporting Side Effects:

If you experience any side effects, report them to your healthcare provider or directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

Always consult with your healthcare provider for personalized medical advice before starting or stopping any medication.